The Albanese Labor Government is taking a significant step forward in cancer research and care by establishing the Cancer Genomics Clinical Trials Fund to drive advancements in genomic medicine and ensure equitable access to cancer clinical trials incorporating genomics.
This initial $3 million investment will be open to Australia's 14 Multi-site Collaborative Cancer Clinical Trials Groups as part of the Support for Cancer Clinical Trials (SCCT) program. This new Fund is a significant first step in implementing the National Framework for Genomics in Cancer Control, addressing key objectives for genomics-informed diagnosis, treatment, clinical trials, research and data.
The Cancer Clinical Trials Groups, which develop investigator-initiated cancer clinical trials independent of industry, focus on areas of unmet need. By funding these groups, the Cancer Genomics Clinical Trials Fund aims to deliver the actions outlined in the Genomics Framework, in line with the SCCT program objectives. It will foster innovation in clinical trial design, using genomics and molecular targeting techniques, accelerating the translation of genomic medicine into clinical practice.
Consultation with the Cancer Clinical Trials Groups is underway to ensure the design of the Fund is robust and aligned with sector needs. This collaborative approach will help maximise the impact of this investment on cancer research and patient outcomes.
It is important that all Australians have equitable access to genomic medicine. This is not the case for many including those from underserved populations. The Cancer Genomics Clinical Trials Fund is a new opportunity to progress advancements in genomic medicine and ensure equitable access to cancer clinical trials incorporating genomics.
Quotes attributable to Mark Butler, Minister for Health and Aged Care
"We are living through a supercharged period of discovery that promises to extend the health and wellbeing of Australians, and the Australian Government is proud to fund this important work."
"The Cancer Genomics Clinical Trials Fund demonstrates our commitment to harnessing the power of genomics to revolutionise cancer care for all Australians. By supporting innovative research and clinical trials, we are paving the way for more personalised and effective cancer treatments, offering new hope to patients across the country."
Quotes attributable to Professor Dorothy Keefe, CEO Cancer Australia
"Genomics is a rapidly advancing field, and by embedding genomics into clinical trials, we can enhance our understanding of cancer and potentially offer new management options for patients. This approach may be particularly valuable when exploring treatments for those who have not responded to existing therapies or are waiting for new treatments to become available."
"Collaboration with the sector will ensure the Cancer Genomics Clinical Trials Fund's investment in genomic medicine translates into the greatest possible impact and real benefits for patients."
